As the new “super drug” Alli hits the stores in the US, many people are asking if the treatment is right for them, and what exactly can it do. It seems that the fact the drug is now available Over The Counter (OTC) has opened up a market perhaps far greater than GlaxoSmithkline had original thought. It is not only obesity sufferers are looking towards the treatment, but people who are “borderline” obese, with the potential for future problems. We may be entering a phase of preventative medicine rather than reactive medicine, but is it right and will it have the same impact? [click to continue…]
{ 8 comments }
